Keyword: Senti Biosciences
Celgene brings on Keytruda R&D exec Alise Reicin in shake-up; IBM Watson Health chief Deborah DiSanzo steps down; and AbbVie CFO Bill Chase to retire.
In his new role as chief scientific officer, Gary Lee will head up the expansion of Senti’s synthetic biology platform.
This year’s class of Fierce 15 landed during a banner year for venture capital investment in biotech. We asked them if they thought the trend would continue or if the bubble would burst.
Adding genetic circuits to make cell and gene therapies safer and better.
All of our Fierce 15 winners care deeply about biomedical science and understand the unique pressure to translate every penny they've raised into something truly innovative for patients. And it seems this passion is infectious when it comes to luring investors.